Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

BSX

Boston Scientific Corporation

Healthcare · USD

Set alert

Price alert · BSX

All alert types
41.98 USD -0.71 -1.66%
As of Oct 30, 2026 Extended hours 42.00 +0.05%
Bid
41.95 × 500
Ask
41.97 × 300
41.73 Day range 43.28
41.58 52-week range 104.98
YTD
-55.97%
1 year
-58.26%
Open
42.95
Prev close
42.69
Mkt cap
60.84B
Vol
22.47M
Avg vol
19.54M
EPS
2.37
P/E
17.71
Div yield
0.00%
More statistics
Low
41.73
High
43.28
Forward P/E
13.16
Beta
0.57
Short ratio
2.17
Inst. own
94.93%
Dividend
0.00
Ex-div date
Earnings
Feb 3, 2027
50-d avg
44.94
200-d avg
56.78
1y target
51.53

5D chart

Chart tools
Interval
1m5m15m30m
BSX five-day price chart39.641.242.844.446.1Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

2.89 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 3
  • P/B 1

Valuation

P/E 48.6×
FY 2016: 83.2×FY 2017: 310×FY 2018: 29.2×FY 2019: 13.4×FY 2020: -443×FY 2021: 61.3×FY 2022: 103×FY 2023: 53.5×FY 2024: 70.9×FY 2025: 48.6×
FY 2016 5y median 61.3× FY 2025
P/S 7.0×
FY 2016: 3.5×FY 2017: 3.8×FY 2018: 5.0×FY 2019: 5.9×FY 2020: 5.1×FY 2021: 5.1×FY 2022: 5.2×FY 2023: 5.9×FY 2024: 7.8×FY 2025: 7.0×
FY 2016 5y median 5.9× FY 2025
P/B 5.8×
FY 2016: 4.4×FY 2017: 4.8×FY 2018: 5.6×FY 2019: 4.5×FY 2020: 3.3×FY 2021: 3.6×FY 2022: 3.8×FY 2023: 4.4×FY 2024: 6.0×FY 2025: 5.8×
FY 2016 5y median 4.4× FY 2025
P/FCF 38.6×
FY 2016: 49.3×FY 2017: 30.7×FY 2018: -8134×FY 2019: 45.8×FY 2020: 45.0×FY 2021: 45.9×FY 2022: 72.4×FY 2023: 49.3×FY 2024: 49.7×FY 2025: 38.6×
FY 2016 5y median 49.3× FY 2025
EV/EBITDA 29.7×
FY 2016: 28.3×FY 2017: 19.6×FY 2018: 21.5×FY 2019: 33.0×FY 2020: 38.8×FY 2021: 27.0×FY 2022: 27.2×FY 2023: 26.8×FY 2024: 36.1×FY 2025: 29.7×
FY 2016 5y median 27.2× FY 2025
EV/Sales 7.5×
FY 2016: 4.1×FY 2017: 4.3×FY 2018: 5.7×FY 2019: 6.8×FY 2020: 5.9×FY 2021: 5.7×FY 2022: 5.9×FY 2023: 6.5×FY 2024: 8.5×FY 2025: 7.5×
FY 2016 5y median 6.5× FY 2025
FCF Yield 2.6%
FY 2016: 2.0%FY 2017: 3.3%FY 2018: -0.0%FY 2019: 2.2%FY 2020: 2.2%FY 2021: 2.2%FY 2022: 1.4%FY 2023: 2.0%FY 2024: 2.0%FY 2025: 2.6%
FY 2016 5y median 2.0% FY 2025

Profitability

Gross Margin 69.0%
FY 2016: 63.7%FY 2017: 64.9%FY 2018: 65.9%FY 2019: 64.1%FY 2020: 56.2%FY 2021: 62.8%FY 2022: 60.8%FY 2023: 62.0%FY 2024: 61.3%FY 2025: 69.0%
FY 2016 5y median 62.0% FY 2025
Operating Margin 19.8%
FY 2016: 14.7%FY 2017: 16.9%FY 2018: 17.7%FY 2019: 15.9%FY 2020: 6.1%FY 2021: 16.2%FY 2022: 14.4%FY 2023: 15.3%FY 2024: 15.7%FY 2025: 19.8%
FY 2016 5y median 15.7% FY 2025
Net Margin 14.4%
FY 2016: 4.1%FY 2017: 1.1%FY 2018: 17.0%FY 2019: 43.8%FY 2020: -0.8%FY 2021: 8.7%FY 2022: 5.5%FY 2023: 11.2%FY 2024: 11.1%FY 2025: 14.4%
FY 2016 5y median 11.1% FY 2025
ROE 11.9%
FY 2016: 5.2%FY 2017: 1.5%FY 2018: 19.2%FY 2019: 33.9%FY 2020: -0.5%FY 2021: 6.3%FY 2022: 4.0%FY 2023: 8.3%FY 2024: 8.5%FY 2025: 11.9%
FY 2016 5y median 8.3% FY 2025
ROIC 8.8%
FY 2016: 8.5%FY 2017: 1.1%FY 2018: 9.7%FY 2019: 6.3%FY 2020: 2.2%FY 2021: 6.6%FY 2022: 3.9%FY 2023: 5.7%FY 2024: 6.1%FY 2025: 8.8%
FY 2016 5y median 6.1% FY 2025
ROA 6.6%
FY 2016: 1.9%FY 2017: 0.5%FY 2018: 8.0%FY 2019: 15.4%FY 2020: -0.3%FY 2021: 3.2%FY 2022: 2.1%FY 2023: 4.5%FY 2024: 4.7%FY 2025: 6.6%
FY 2016 5y median 4.5% FY 2025

Growth (YoY)

Revenue 19.9%
FY 2016: 12.2%FY 2017: 7.9%FY 2018: 8.6%FY 2019: 9.3%FY 2020: -7.7%FY 2021: 19.9%FY 2022: 6.7%FY 2023: 12.3%FY 2024: 17.6%FY 2025: 19.9%
FY 2016 FY 2025
Operating Income 50.7%
FY 2016: 56.5%FY 2017: 23.4%FY 2018: 13.9%FY 2019: -1.4%FY 2020: -64.9%FY 2021: 219.8%FY 2022: -5.1%FY 2023: 19.6%FY 2024: 20.8%FY 2025: 50.7%
FY 2016 FY 2025
EPS (diluted) 55.2%
FY 2016: 238.9%FY 2017: -70.1%FY 2018: 1493.0%FY 2019: 180.0%FY 2020: -102.4%FY 2021: 946.1%FY 2022: -35.1%FY 2023: 140.6%FY 2024: 16.5%FY 2025: 55.2%
FY 2016 FY 2025
Free Cash Flow 38.3%
FY 2016: 68.8%FY 2017: 85.7%FY 2018: -100.5%FY 2019: 23016.7%FY 2020: -17.7%FY 2021: 16.3%FY 2022: -30.5%FY 2023: 86.3%FY 2024: 55.3%FY 2025: 38.3%
FY 2016 FY 2025

Financial Health

Current Ratio 1.6×
FY 2016: 0.9×FY 2017: 0.7×FY 2018: 0.8×FY 2019: 1.0×FY 2020: 1.8×FY 2021: 1.5×FY 2022: 1.5×FY 2023: 1.3×FY 2024: 1.1×FY 2025: 1.6×
FY 2016 5y median 1.5× FY 2025
Quick Ratio 1.1×
FY 2016: 0.6×FY 2017: 0.5×FY 2018: 0.5×FY 2019: 0.6×FY 2020: 1.5×FY 2021: 1.1×FY 2022: 1.0×FY 2023: 0.8×FY 2024: 0.6×FY 2025: 1.1×
FY 2016 5y median 1.0× FY 2025
Debt / Equity 0.5×
FY 2016: 0.8×FY 2017: 0.8×FY 2018: 0.8×FY 2019: 0.7×FY 2020: 0.6×FY 2021: 0.6×FY 2022: 0.5×FY 2023: 0.5×FY 2024: 0.5×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
Net Debt / EBITDA 2.0×
FY 2016: 4.3×FY 2017: 2.7×FY 2018: 2.7×FY 2019: 4.5×FY 2020: 5.2×FY 2021: 3.0×FY 2022: 3.0×FY 2023: 2.5×FY 2024: 2.7×FY 2025: 2.0×
FY 2016 5y median 2.7× FY 2025
Interest Coverage 11.4×
FY 2016: 5.3×FY 2017: 6.6×FY 2018: 6.5×FY 2019: 3.3×FY 2020: 1.3×FY 2021: 5.5×FY 2022: 3.9×FY 2023: 8.0×FY 2024: 6.8×FY 2025: 11.4×
FY 2016 5y median 6.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.1%FY 2021: 0.1%FY 2022: 0.1%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -34.1%FY 2021: 5.3%FY 2022: 7.9%FY 2023: 1.8%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 1.8% FY 2025

Annual · latest fiscal year ends 2025-12-31